Major medical cannabis research project announced by Glass Pharms and the James Hutton Institute
Technology tamfitronics Glass Pharms and the Advanced Plant Growth Centre at The James Hutton Institute are to conduct a ground-breaking medical cannabis research program that has been funded by UKRI’s Biotechnology and Biological Sciences Research Council (BBSRC). The three-year project will aim to support the growing need for medicinal cannabis by helping standardise the product to meet pharmaceutical quality though environment manipulation and the development of new cannabis plant architectures.Currently cannabis varieties, or cultivars, vary greatly creating different cannabinoid profiles. The research in Dundee will aim to use Controlled Environment Agriculture (CEA) technologies to create a consistent product and help the UK to maintain its position as the world's largest producer and exporter of medicinal cannabis.The plants will be grown to maturity at Glass Pharms’ purpose-built 2.4-hectare semi-closed glasshouse facility that has advanced sensor technology...